Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1000275 TORONTO, A6
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,950
+$11,476 QoQ
Shares Held
2,559
+2125.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 89 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. XFOR ranks #271 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in XFOR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,950 2,559
2026-03-31 $474 115
2025-12-31 $416 104
2025-09-30 $8,661 2,533
2025-06-30 $5,860 3,085
2025-03-31 $3,640 15,428
2024-12-31 $7,887 10,747
2024-09-30 $13,060 19,523
2024-06-30 $9,166 15,805
2024-03-31 $3,975 2,861
2023-12-31 $32,988 39,321
2023-09-30 $19,666 18,043
2023-06-30 $19,871 10,243
2022-09-30 $172 101
2021-06-30 $13,415 2,064
2021-03-31 $14,843 1,724
2020-12-31 $5,632 876
2020-09-30 $209 31
2020-03-31 $1,018 102